ASCENTAGE PHARMA GR-ADR (AAPG) Stock Income Statement
NASDAQ:AAPG - Nasdaq - ADR - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 903.03M | 221.98M | 209.71M | 27.91M | 12.45M | |||
| Minority Interest Expense | 252.00K | 75.00K | N/A | N/A | N/A | |||
| Cost Of Goods | 27.45M | 30.54M | 22.00M | 3.33M | 1.97M | |||
| Gross Profit | 875.58M | 191.44M | 187.71M | 24.58M | 10.48M | |||
| Operating Expenses | 1.21B | 1.07B | 1.04B | 917.83M | 698.24M | |||
| Research and Development | 841.24M | 706.97M | 743.10M | 766.49M | 564.57M | |||
| Selling, General, and Administrative Expenses | 378.43M | 376.46M | 328.02M | 191.26M | 130.34M | |||
| Operating Income | -329.93M | -874.04M | -852.93M | -893.25M | -687.75M | |||
| Interest Income/Expense | -40.44M | -58.83M | -36.30M | 61.00M | 12.31M | |||
| Non Recurring Items | N/A | 4.00K | 2.07M | N/A | N/A | |||
| Income Before Taxes | -370.36M | -932.86M | -887.17M | -832.25M | -675.45M | |||
| Income Tax | -9.83M | -7.15M | -4.25M | -49.83M | 2.16M | |||
| Net Income | -360.28M | -925.64M | -882.92M | -782.42M | -677.61M | |||
| EBITDA | N/A | -796.73M | -791.46M | -864.92M | -660.33M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.17 | -10.99 | -11.22 | -10.30 | -10.52 | |||
| Statistics | ||||||||
| Gross Profit Margin | 96.96% | 86.24% | 89.51% | 88.08% | 84.21% | |||
| Profit Margin | -39.90% | -416.98% | -421.02% | -2803.38% | -5442.62% | |||
| Operating Profit Margin | -36.54% | -393.74% | -406.72% | -3200.45% | -5524.14% | |||
All data in CNY